Platform Overview
One Platform. Connected Biomedical Intelligence.
ANISOR unifies biomedical knowledge across diseases, genes, proteins, pathways, biomarkers, targets, molecules and clinical research into a single evidence-driven platform.
Why a Unified Platform
Why a Unified Platform
Researchers often move across multiple disconnected resources. ANISOR is designed to reduce fragmentation by providing a connected research experience.
Scientific Intelligence Suite
Eight connected intelligence modules
Each module focuses on one layer of biomedical evidence — linked together within the same connected platform, so research context is never lost between them.
Disease Intelligence
Explore disease biology, mechanisms and connected evidence in one place.
Learn moreGene Intelligence
Examine gene-level evidence in the context of disease and biological function.
Learn morePathway Intelligence
Trace signaling pathways and the biological relationships between them.
Learn moreBiomarker Intelligence
Evaluate biomarkers across evidence types and research modalities.
Learn moreTarget Intelligence
Assess and prioritize therapeutic targets with connected supporting evidence.
Learn moreClinical Intelligence
Bring clinical trial and outcomes evidence into the same connected view.
Learn moreResearch Intelligence Platform
The infrastructure behind every module
A shared layer of intelligence powers every module in the Scientific Intelligence Suite, so evidence stays connected and traceable end to end.
Knowledge Graph
A connected map of biomedical entities and the relationships between them.
Semantic Search
Search across biomedical evidence using natural, contextual queries.
Evidence Explorer
Navigate the supporting evidence behind every connection in the platform.
AI-assisted Research
Use AI-assisted tools to help synthesize and navigate research evidence.
Explainability
Understand how evidence and connections are surfaced, so every insight stays traceable back to its source.
Connected Workflow
Move fluidly across the evidence chain
Follow a single research thread from disease biology through biological entities, treatments and clinical studies, all the way to the evidence that supports it — without switching tools.